214 related articles for article (PubMed ID: 2480971)
1. Blood eosinophils and eosinophil-derived proteins in allergic asthma.
Durham SR; Loegering DA; Dunnette S; Gleich GJ; Kay AB
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):931-6. PubMed ID: 2480971
[TBL] [Abstract][Full Text] [Related]
2. Intracellular expression and serum levels of eosinophil peroxidase (EPO) and eosinophil cationic protein in asthmatic children.
Krug N; Napp U; Enander I; Eklund E; Rieger CH; Schauer U
Clin Exp Allergy; 1999 Nov; 29(11):1507-15. PubMed ID: 10520079
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
8. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology.
Trocmé SD; Hallberg CK; Gill KS; Gleich GJ; Tyring SK; Brysk MM
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):593-9. PubMed ID: 9071212
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
[TBL] [Abstract][Full Text] [Related]
10. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma.
Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB
Clin Exp Allergy; 1992 Feb; 22(2):265-73. PubMed ID: 1373987
[TBL] [Abstract][Full Text] [Related]
11. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
[TBL] [Abstract][Full Text] [Related]
12. The molecular biology of eosinophil granule proteins.
Hamann KJ; Barker RL; Ten RM; Gleich GJ
Int Arch Allergy Appl Immunol; 1991; 94(1-4):202-9. PubMed ID: 1657792
[TBL] [Abstract][Full Text] [Related]
13. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx.
Bascom R; Pipkorn U; Proud D; Dunnette S; Gleich GJ; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1989 Sep; 84(3):338-46. PubMed ID: 2778240
[TBL] [Abstract][Full Text] [Related]
14. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation.
Tomassini M; Tsicopoulos A; Tai PC; Gruart V; Tonnel AB; Prin L; Capron A; Capron M
J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):365-75. PubMed ID: 1890265
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children.
Niggemann B; Kleinau I; Schmitt M; Wahn U
Allergy; 1994 Feb; 49(2):74-80. PubMed ID: 8172362
[TBL] [Abstract][Full Text] [Related]
16. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
17. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction.
Leiferman KM; Fujisawa T; Gray BH; Gleich GJ
Lab Invest; 1990 May; 62(5):579-89. PubMed ID: 2188046
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
19. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis.
Koller DY; Nilsson M; Enander I; Venge P; Eichler I
Clin Exp Allergy; 1998 Feb; 28(2):241-8. PubMed ID: 9515599
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.
Motojima S; Frigas E; Loegering DA; Gleich GJ
Am Rev Respir Dis; 1989 Mar; 139(3):801-5. PubMed ID: 2923379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
